Safety, Reactogenicity & Immunogenicity Study to Evaluate a Booster Dose of GSK Biologicals' Hib-MenC Given With Priorixâ„¢ in Toddlers (13-14 m) Primed With 3 Doses of Hib and MenC-CRM197